Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Loeffler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Research Square|July 18, 2023
Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle VaccinePeter J Halfmann, Kathryn Loeffler, Augustine Duffy, et al.
Bioengineering & Translational Medicine|September 30, 2021
Potent neutralization of SARS-CoV-2 including variants of concern by vaccines presenting the receptor-binding domain multivalently from nanoscaffoldsPeter J Halfmann, Ana Castro, Kathryn Loeffler, et al.
Chemistry (Basel, Switzerland)|September 29, 2025
Tethered Antigenic Suppression Shields the Hemagglutinin Head Domain and Refocuses the Antibody Response to the Stalk DomainDonguk Kim, Kathryn Loeffler, Yixin Hu, et al.
Nanotechnology|September 14, 2010
Enhanced microcontact printing of proteins on nanoporous silica surfaceEllen Blinka, Kathryn Loeffler, Ye Hu, et al.
Bioengineering & Translational Medicine|November 18, 2024
Single immunization with an influenza hemagglutinin nanoparticle-based vaccine elicits durable protective immunityShiho Chiba, Tadashi Maemura, Kathryn Loeffler, et al.
Nature Communications|February 12, 2024
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccinePeter J Halfmann, Kathryn Loeffler, Augustine Duffy, et al.
Science Advances|February 21, 2025
A modular cell-free protein biosensor platform using split T7 RNA polymeraseMegan A McSweeney, Alexandra T Patterson, Kathryn Loeffler, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
A modular cell-free protein biosensor platform using split T7 RNA polymeraseMegan A McSweeney, Alexandra T Patterson, Kathryn Loeffler, et al.
NPJ Vaccines|November 3, 2025
Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza virusesAsim Biswas, Kathryn Loeffler, Donguk Kim, et al.
Ebiomedicine|November 14, 2022
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesPeter J Halfmann, Steven J Frey, Kathryn Loeffler, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Research Square|July 18, 2023
Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle VaccinePeter J Halfmann, Kathryn Loeffler, Augustine Duffy, et al.
Bioengineering & Translational Medicine|September 30, 2021
Potent neutralization of SARS-CoV-2 including variants of concern by vaccines presenting the receptor-binding domain multivalently from nanoscaffoldsPeter J Halfmann, Ana Castro, Kathryn Loeffler, et al.
Chemistry (Basel, Switzerland)|September 29, 2025
Tethered Antigenic Suppression Shields the Hemagglutinin Head Domain and Refocuses the Antibody Response to the Stalk DomainDonguk Kim, Kathryn Loeffler, Yixin Hu, et al.
Nanotechnology|September 14, 2010
Enhanced microcontact printing of proteins on nanoporous silica surfaceEllen Blinka, Kathryn Loeffler, Ye Hu, et al.
Bioengineering & Translational Medicine|November 18, 2024
Single immunization with an influenza hemagglutinin nanoparticle-based vaccine elicits durable protective immunityShiho Chiba, Tadashi Maemura, Kathryn Loeffler, et al.
Nature Communications|February 12, 2024
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccinePeter J Halfmann, Kathryn Loeffler, Augustine Duffy, et al.
Science Advances|February 21, 2025
A modular cell-free protein biosensor platform using split T7 RNA polymeraseMegan A McSweeney, Alexandra T Patterson, Kathryn Loeffler, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
A modular cell-free protein biosensor platform using split T7 RNA polymeraseMegan A McSweeney, Alexandra T Patterson, Kathryn Loeffler, et al.
NPJ Vaccines|November 3, 2025
Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza virusesAsim Biswas, Kathryn Loeffler, Donguk Kim, et al.
Ebiomedicine|November 14, 2022
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesPeter J Halfmann, Steven J Frey, Kathryn Loeffler, et al.
Pageof 2